Uncategorized

At John Schliesser, our commitment to advancing medical science through rigorous clinical trials has led to several notable breakthroughs in recent years. These advancements represent significant strides towards improving patient outcomes and addressing critical healthcare challenges. Here are some of the recent breakthroughs from our clinical trials: 1. Advancement in Cancer Treatments Through innovative trials […]

Clinical trials conducted at John Schliesser adhere to stringent ethical standards to protect participant safety, uphold scientific integrity, and maintain public trust in medical research. Ethics play a fundamental role in every phase of our trials, guiding our practices and ensuring the welfare of all individuals involved. Informed Consent: A Foundation of Ethical Practice Informed

Clinical trials are structured into distinct phases, each serving a specific purpose in the research and development of new treatments and therapies. At John Schliesser, we conduct trials across these phases to ensure rigorous testing and evaluation of potential medical advancements. Phase 1: Safety and Dosage Phase 1 trials are the first step in testing

Clinical trials are at the forefront of medical research, playing a pivotal role in advancing healthcare and improving treatments for various conditions. At John Schliesser, we recognize the crucial importance of patient participation in these trials, as it not only drives scientific discovery but also directly benefits the individuals involved and the broader community. Advancing